Summary The expression of 5T4, an oncotrophoblast cell surface antigen was examined in 72 colorectal and 27 gastric carcinomas, with immunoperoxidase technique, on frozen sections.
It has been shown that certain human tumour tissues and cell lines express membrane antigens otherwise found only on placental trophoblast and absent on normal tissues (e.g. Loke et al., 1980; McLaughlin et al., 1982) . These proteins may exist to protect the semi-allogeneic foetus from immunological rejection and in a similar way allow tumour cells to evade host immunity. An improvement of understanding the role of these antigens in human cancer is likely to be the basis for achieving new approaches to both its identification and treatment.
The 5T4 trophoblast cell surface antigen (Hole & Stern, 1988; shows a restricted pattern of expression in normal human tissues, but the antigen is present in a wide variety of transformed cell lines (Hole & Stern, 1988) and carcinomas (Southall et al., 1990; Jones et al., 1990) . In these investigations of 5T4 antigen expression in limited numbers of different human carcinomas, no conclusions could be drawn as to possible correlations with established prognostic factors.
The objective of the present study was to determine the relationship between 5T4 expression, tumour growth and stage of disease, in order to investigate the difference, if any, between 5T4 positive and negative carcinomas from the colon and stomach.
Materials and methods
Seventy-two colorectal and 27 gastric carcinomas were included in this study. Gastric specimens and 33 colorectal cancers were obtained at the Pomeranian Medical Academy, Szczecin, Poland, the other colorectal neoplasms were from various Departments of Surgery, Manchester. The histological type and stage of tumour (Table II) as well as the grading (Table III) were assessed from routine examination of paraffin-embedded sections, stained with haematoxylin and eosin. The stage of grouping was made according to the criteria of Dukes and to the criteria of the Japanese Research Society, for colorectal and gastric cancer respectively. Hole & Stern, 1988 ) diluted 1/20 for 1 h, biotinylated rabbit anti-mouse antibodies diluted 1/400 for 30 min (DAKO Ltd) and streptavidin HRP-conjugated reagent diluted 1/800 for 30 min. Peroxidase was visualised using a solution of diaminobenzidine tetrahydrochloride (DAB Sigma) in TBS containing 0.03% hydrogen peroxide. Positive (monoclonal anti-cytokeratin antibody, LP34, DAKO Ltd.) and negative controls (omission of the primary antibody) were run in each test. Placental villous sections were included in each experiment to ensure that the procedure was working optimally.
Statistical analysis
The distribution of 5T4 antigen was compared with tumour grade and stage of disease. Statistical analysis was done with chi-square test, using significance level of 0.05.
Results
The results of immunohistochemical evaluation are summarised in Table I . Overall the proportion of tumour specimens labelled with mAb 5T4 was 85% for colorectal and 81% for gastric carcinoma. However, there were two distinct patterns of immunohistochemical staining, either detection of positive labelling of the malignant cells and surrounding stroma (40% of colorectal and 56% of the gastric tumours) or strong positive reactivity of stromal elements alone (45% of colorectal and 26% of gastric tumours). When the tumour cells were labelled for 5T4 antigen, there was reactivity in all or nearly all malignant cells as evidenced by congruency with cytokeratin labelling. Only 11 colorectal and three gastric carcinomas showed a focal reactivity. The cellular localisation appeared to be mostly membranous; only in three colorectal and one gastric cancer was labelling principally cytoplasmic. For stromal labelling, the intensity of expression diminished with distance from the tumour cells. In normal colorectal and gastric epithelium 5T4 antigen was not detected although a weak expression in the stroma was observed in nine out of 30 specimens. In normal gastric and colonic tissue adjacent to carcinoma, mucous glands were also weakly positive.
A positive correlation is observed between 5T4 expression in cancer cells and the stage of disease (Table II) . The 5T4 positive staining of malignant cells is more frequent in tumours from patients presenting with lymph-node or distal metastases while 5T4 negative neoplasms surrounded by posi- (Table   III) . Other studies have indicated changes in expression of several cell surface glycoproteins in metastasis. Johnson et al. (1989) demonstrated that the expression of intracellularadhesion molecule 1, in human melanoma correlates with increased risk of metastases. Tandon et al. (1990) described association between the 323/A3 surface glycoprotein and poor prognosis in breast cancer. These authors found that breast carcinomas larger then 2 cm, without oestrogen receptors, which had involved regional lymph nodes, expressed the 323/A3 antigen more frequently than small, localised and oestrogen receptor positive neoplasms. Investigations on experimentally induced carcinomas have also demonstrated a relationship between tumour progression and a change on the surface of malignant cells (Damen et al., 1991; Nalei et al., 1990; Heffernan et al., 1989; Dennis et al., 1987) .
Our results on a positive correlation of the 5T4 expression in cancer cells and their metastatic ability may be important for further therapeutic strategies. The 5T4 mAb is currently being assessed for tumour localisation and may be a useful target in immunotherapy. The ultimate exploitation of the malignancy associated expression of 5T4 molecules in cancer will be influenced by the type of molecule. Using molecular biological approaches to isolate the encoding gene for 5T4 molecules will allow the evaluation of possible relationships to other families of surface molecules such as those with cell adhesion roles.
